ArticleAnnals of hematology2023

Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis.

Martin Stork et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.